Abstract:Background: Epsins are a family of ubiquitin-binding, endocytic clathrin adaptors. Mice lacking both epsins 1 and 2 (Epn1/2) die at embryonic day 10 and exhibit an abnormal vascular phenotype. We have recently published that endothelial epsins function as critical regulators of tumor angiogenesis by controlling the endocytosis of VEGFR2 (J Clin Invest. 2012). The goal of this project is to define the novel role of epsins in endothelial cells (EC) and macrophages in regulating inflammation-mediated atherosclerosis. Methods and Results: To examine the role of endothelial and macrophage epsins in atherogenesis, we engineered mice with specific deletion of epsins in EC (EC-DKO) or myeloid cells (MΦ-DKO). Strikingly, these mice are viable but display markedly attenuated atherogenesis. Mice with either EC-DKO or MΦ-DKO on ApoE-/- background had a significant reduction in atherosclerotic lesion formation and macrophage infiltration compared to ApoE-/- mice fed a western diet. FACS analysis revealed that epsin deficiency greatly reduced TNFα and LPS-induced expression of adhesion molecules including ICAM-1, VCAM-1, P- and E-selectins, and CCR2 and MCP-1 in primary mouse aortic EC, and leukocyte recruitment in mouse aorta. Mechanistically, epsins promote TNFR/TLRs signaling and NF-κB and MAPK (JNK and p38) activation by enhancing recruitment of NEMO, an essential NF-kB activator. Conversely, in macrophages, epsin deficiency produces no change in LDL and scavenger receptor expression but impaired pinocytosis of Lucifer Yellow, indicative of a major defect in LDL lipid uptake. We also observed that a synthetic peptide comprising the epsin ubiquitin-interacting motif (UIM) and lesion homing sequence potently disrupts association of epsins with TNFR/TLR signaling complex in vitro, and inhibits atherosclerotic plaque in vivo. Our data show that epsins control atherosclerosis by promoting TNFR/TLR signaling in endothelial cells, facilitating LDL lipid uptake in macrophages, and provide a potential novel strategy to perturb atheroma progression. Conclusion: Our results demonstrate a novel proatherogenic role of epsins in atherosclerosis by potentiating endothelium inflammation, augmenting leukocyte recruitment, and promoting foam cell formation.

Genetic reduction of vascular endothelial growth factor receptor 2 rescues aberrant angiogenesis caused by epsin deficiency.

Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition

Endothelial TIE1 Restricts Angiogenic Sprouting to Coordinate Vein Assembly in Synergy with Its Homologue TIE2

Abstract 13426: Suppression of Epsin Expression Rescues Diabetes Triggered Impaired Lymphatic Function by Limiting VEGFR3 Degradation

Direct Evidence for Endothelial Vascular Endothelial Growth Factor Receptor-1 Function in Nitric Oxide-Mediated Angiogenesis

Abstract 12764: Endothelial-Specific Deletion of Epsins Attenuates Atherosclerosis in ApoE-Deficient Mouse Model

Abstract 12274: Endothelium-specific Deletion of Epsins Attenuates Atherosclerosis Through Maintaining ER Homeostasis

Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis

Abstract 10738: the Novel Role of Epsins in Atherosclerosis

Endothelial Scaffolding Protein ENH (Enigma Homolog Protein) Promotes PHLPP2 (Pleckstrin Homology Domain and Leucine-Rich Repeat Protein Phosphatase 2)-Mediated Dephosphorylation of AKT1 and eNOS (Endothelial NO Synthase) Promoting Vascular Remodeling.

Epsins in vascular development, function and disease

Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis

Regulation of Vasculogenesis and Angiogenesis by EphB/ephrin-B2 Signaling Between Endothelial Cells and Surrounding Mesenchymal Cells

E-Prostanoid 3 Receptor Mediates Sprouting Angiogenesis Through Suppression of the Protein Kinase A/β-Catenin/Notch Pathway

Abstract TP2: Increase of EphrinB2/EphB4 Signaling Reduces the Severity of Brain Arteriovenous Malformation in Endoglin Deficient Mice Through Reduction of Angiogenesis and Inflammation

Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization

Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and function.

Epsin-mediated Degradation of IP3R1 Fuels Atherosclerosis.

Motif Mimetic of Epsin Perturbs Tumor Growth and Metastasis

The role of erythropoietin in regulating angiogenesis.